Results 211 to 220 of about 157,713 (224)

Impact of BMPR2 mutation on the severity of pulmonary arterial hypertension: a systematic review and meta-analysis. [PDF]

Respir Res
Wu J, Huang Q, Zhang Y, De Z, Fu H, Zhan Y, Gu Y, Xie J.   +7 more
europepmc   +1 more source

DanGer Shock‐like profile predicts the outcome in ST‐elevation myocardial infarction‐related cardiogenic shock

ESC Heart Failure, EarlyView.
Flow chart illustrates the analysed patients as well as main baseline characteristics and outcomes comparing DanGer Shock‐like versus DanGer Shock‐unlike patients. The composite safety endpoint comprises severe bleeding, limb ischaemia, haemolysis, device failure, and worsening of aortic regurgitation. CS indicates cardiogenic shock.
Norman Mangner, Johannes Mierke, Dominik Baron, Felix J. Woitek, Stephan Haussig, Thomas Nowack, Ephraim B. Winzer, Julia Fischer, Robert Höllriegel, Stefanie Jellinghaus, Axel Linke   +10 more
wiley   +1 more source

Arduous management in treatment of elderly patient with pulmonary arterial hypertension and cardiopulmonary comorbidities. [PDF]

Respir Med Case Rep
Enomoto Y, Kusaka K, Sato K, Takeda K, Kawashima M, Morio Y.   +5 more
europepmc   +1 more source

Left atrial to coronary sinus shunting in more advanced heart failure with preserved ejection fraction

ESC Heart Failure, EarlyView.
Abstract Aims Inter‐atrial shunt device therapy has shown mixed results in clinical trials, with clinical ‘non‐responders’ typically showing features of more advanced heart failure. We aimed to analyse the haemodynamic and clinical response of a novel left atrial to coronary sinus (LA‐CS) shunt device in patients with higher natriuretic peptide (NP ...
Ryan J. Tedford, Brian A. Houston, JoAnn Lindenfeld, Rami Kahwash, Marcus A. Urey, Nicholas S. Amoroso, Benjamin Hibbert, Firas Zahr, William A. Gray, Javed Butler   +9 more
wiley   +1 more source

Medication adherence and clinical outcome in patients with pulmonary arterial hypertension or distal chronic thromboembolic pulmonary hypertension. [PDF]

BMJ Open Respir Res
Reimann L, Preiss H, Müller J, Huber P, Mayer L, Langleben D, Ulrich S, Lichtblau M.   +7 more
europepmc   +1 more source

Signs of congestion, quality of life and short‐term rehospitalization in patients with heart failure

ESC Heart Failure, EarlyView.
Abstract Aims Signs of congestion are a treatment target in patients with heart failure (HF), as they affect patients' well‐being, and congestion scores are associated with the risk of early readmission. However, which individual sign of congestion has the strongest association with quality of life (QoL) and HF rehospitalization remains uncertain ...
Geert H.D. Voordes, Adriaan A. Voors, Hailun Qin, Jozine M. ter Maaten, Kevin Damman   +4 more
wiley   +1 more source

Cardiac Involvement and Heart Failure Staging in Patients with Systemic Sclerosis Without Pulmonary Arterial Hypertension. [PDF]

J Clin Med
Oliveira MI, Bragança B, Gomes JR, Santos M.   +3 more
europepmc   +1 more source

Prognostic implications of functional tricuspid regurgitation in asymptomatic degenerative mitral regurgitation

ESC Heart Failure, EarlyView.
Abstract Aims Functional tricuspid regurgitation (FTR) associated with degenerative mitral regurgitation (DMR) accentuates the severity of heart failure and is a marker of poor prognosis. Little is known about FTR associated with asymptomatic DMR. Methods and results The study included 1249 asymptomatic patients with moderate or severe DMR from the ...
Christophe Tribouilloy, Yohann Bohbot, Benjamin Essayagh, Giovanni Benfari, Jeroen J. Bax, Thierry Le Tourneau, Yan Topilsky, Clemence Antoine, Dan Rusinaru, Francesco Grigioni, Nina Ajmone Marsan, Aniek van Wijngaarden, Aviram Hochstadt, Jean Christian Roussel, Prabin Thapa, Michelena Hector I, Maurice Enriquez‐Sarano   +16 more
wiley   +1 more source

Pathologic differences between systemic sclerosis-associated and idiopathic pulmonary arterial hypertension. [PDF]

J Scleroderma Relat Disord
Friedman SH, Harley RA, Williams J, Forcucci JA, Ramakrishnan V, Strange C, Silver RM, Feghali-Bostwick C, Argula RG.   +8 more
europepmc   +1 more source

How a Most Unlikely Drug Changed the Outcome of Pulmonary Arterial Hypertension. [PDF]

Pulm Circ
Robbins IM, Hemnes AR.
europepmc   +1 more source